LabGenius Therapeutics
LabGenius Therapeutics
AI-driven drug discovery platform for rapid development of novel therapeutics.
About
LabGenius Therapeutics is an AI-driven drug discovery company that leverages its proprietary platform to accelerate the development of novel therapeutics. Their approach combines advanced machine learning with high-throughput experimentation to identify and optimize drug candidates more efficiently than traditional methods.
Key facts
- Website
- labgeniustx.com
- Headquarters
- London, United Kingdom
- Founded
- 2019
- Total funding
- $3M (Seed)
- Valuation
- Private
- Business model
- B2B
- Tags
- BiotechDrug DiscoveryAI-Driven Protein DesignHealthTechFoundation Model
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 1 Jan 2019 | Seed | $3M | - |
Tech stack
Detected on labgeniustx.com, last scanned 15 Sept 2026. Run your own scan
- Compliance
- GDPR, CCPA
- Frontend
- jQuery
- Analytics
- Google Analytics 4
- SEO
- All in One SEO
- CMS / Builders
- WordPress
- Hiring platform
- Teamtailor
Add first review
Frequently asked
How much funding has LabGenius Therapeutics raised?
LabGenius Therapeutics has raised a total of $3M in funding. The most recent round on record is Seed.